BeWell Innovations

Select clients: AZ Maria Middelares in Gent, University Hospital Antwerp, Chirec Hospital.
Primary contact
Lievevrouwestraat 10
2520 Ranst
Belgium
+32 (0)3 870 46 30
Lievevrouwestraat 10
2520 Ranst
Belgium
+32 (0)3 870 46 30
Sections Remote Monitoring
Funding π°
Total
$638K
Select investors Ark Angels Activator Fund, Business Angels Network Vlaanderen, PMV
Key people π§βπ€βπ§
- Joris Wille - CEO
- Dries Oeyen - IT Manager
- Kathleen De Schutter - Finance & Administration Manager
Highlights β
- Already generates revenue: As of March 2022, several sources suggest BeWell Innovations has an annual revenue of $6 million. π
- Solving a real problem: More than 45 million and 61 million surgical procedures are performed every year in the US and in Europe, respectively. Most conservative estimates suggest that 10% to 15% of those patients will go on to suffer chronic pain one year after surgery. Chronic postsurgical pain (CPSP) is a major public health issue: it affects large numbers of patients, has important economic consequences and has a significant effect on quality of life. Chronic pain after surgery is usually, in part at least, neuropathic, and this makes it hard to treat. An estimated 25% of these patients use opioids to alleviate their pain. A significant part are at risk of over abuse and hence addiction. BeWell Innovation's Well@Home Pain app helps these more than 2.5 million patients and improves their quality of life through its Well@Home platform. π
- Approved by mHealth Belgium: Bewell Innovations' Well@Home app is one of the mHealth apps to be included in the validation pyramid of mHealth Belgium. This approval means that its health app has initiated a first step towards reimbursement for physicians to initiate, respond, act and react upon substantial amounts of health data, refining diagnosis and improving the quality of therapy. Level 1 (M1) criteria include CE declaration as a medical device, registration with the authorities, and compliance with the EU GDPR. Obtaining reimbursement is a level 3 (M3) approval. π
- COVID-19 fighting tech: Bewell Innovations' Well@Home and covidathome.be app were recognized by the governmental Taskforce for Data & Technology against Corona. π
Video βΆοΈ
Awards & Recognitions π
- 2021 Shared Patient Experience Award: COVID-19 Category (together with AZ Maria Middelares) π
Last update:
August 17, 2022
Disclaimer: The content on this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances.